SINGAPORE (AP) — SINGAPORE (AP) — Wave Life Sciences Pte. Ltd. (WVE) on Tuesday reported fourth-quarter profit of $29.3 million.
On a per-share basis, the Singapore-based company said it had profit of 17 cents.
The results topped Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 17 cents per share.
The biopharmaceutical company posted revenue of $83.7 million in the period, which also beat Street forecasts. Seven analysts surveyed by Zacks expected $29.1 million.
For the year, the company reported a loss of $97 million, or 70 cents per share. Revenue was reported as $108.3 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on WVE at https://www.zacks.com/ap/WVE
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.